Reimbursed with a limitationOriginator productATC B02BX04

Nplate

Nplate is an originator product from Amgen Switzerland AG and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 259.70 to CHF 989.50 depending on the pack; the patient co-payment is 10 per cent plus the deductible.

Core data

Authorisation holder
Amgen Switzerland AG
ATC code
B02BX04
IT group
06.99 Varia
Active substances
Romiplostimum
Preparation type
Originator product
On the SL since
01/11/2011
Last price change
01/05/2025
Co-payment
10%

Prices per pack

The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.

Nplate Price table As of 17/09/2026
Dosage formPack sizeEx-factory pricePublic priceValid fromCat.GTIN
Trockensub 125 mcgDurchstf 1 StkCHF 223.68CHF 259.7001/01/2024A7680690650018
Trockensub 250 mcg c SolvDurchstf 1 StkCHF 447.36CHF 502.9501/11/2011A7680615410017
Trockensub 500 mcg c SolvDurchstf 1 StkCHF 894.73CHF 989.5001/11/2011A7680615410024

Limitation

This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.

The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.

FOPH wordingValid from 01/01/2024

Nplate ist für die Behandlung von erwachsenen Patienten mit primärer Immunthrombozytopenie (ITP) indiziert, die gegenüber anderen Therapien refraktär sind (z. B. Kortikosteroide, Immunglobuline).

Nplate ist für die Behandlung von pädiatrischen Patienten im Alter von 1 Jahr oder älter mit chronischer primärer Immunthrombozytopenie (ITP) indiziert, die gegenüber anderen Therapien refraktär sind (z. B. Kortikosteroide, Immunglobuline).

Nplate sollte nur bei Patienten mit erhöhtem Blutungsrisiko infolge ausgeprägter Thrombozytopenie eingesetzt werden.
Patienten, die mit der höchsten wöchentlichen Dosis von Nplate (10 mcg/kg) auch nach 4 Wochen eine Thrombozytenzahl von mindestens 20 x 109/L nicht erreichen, sollten die Behandlung abbrechen.

FAQ

Is Nplate covered by Swiss health insurance?

Yes, but only under conditions. Nplate is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.

What does Nplate cost in Switzerland?

The public price is the maximum price set by the FOPH and for Nplate ranges from CHF 259.70 to CHF 989.50 per pack. The ex-factory price ranges from CHF 223.68 to CHF 894.73. Pharmacies may not charge more, but may charge less.

Correct or complete this entry

Market access

Do you need your product on the Specialities List?

Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.

  • Independent directory
  • Official FOPH data
  • Website in eight languages
Send an enquiry
Contact

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissreimbursement.com